MBBS

The National Institute of Pharmaceutical Education and Research (NIPER) at S.A.S Nagar (Mohali) created as a Centre of Excellence for imparting higher education, research and development in pharmaceutical sciences and management is the first Institute of its kind in the country. The Institute was declared as an Institute of National Importance by Government of India through an Act of Parliament, notified on 26th June 1998. The Institute is a member of the Association of Indian Universities. During the years 2007 and 2008, Government of India established six more NIPERs.

Clinical Development Services Agency (CDSA) is an extramural unit of Translational Health Science and Technology Institute (THSTI) and has been established as a not-for-profit society to provide cost affective, high quality preclinical and clinical product development support services to meet the country’s growing healthcare needs. It will tend enterprises; particularly SMEs involved in new technology innovation and facilitate translation of scientific know-how into viable products.

Post : Program Manager – CPM, CDSA

The promulgation of Employees' State Insurance Act, 1948(ESI Act), by the Parliament was the first major legislation on social Security for workers in independent India. It was a time when the industry was still in a nascent stage and the country was heavily dependent on an assortment of imported goods from the developed or fast developing countries. The deployment of manpower in manufacturing processes was limited to a few select industries such as jute, textile, chemicals etc.

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology (DBT), Ministry of Science and Technology, Govt, of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster (NCR BSC) located at Faridabad, and is designed with the mission to conduct innovative translational research to translate concepts into products to improve human health. We are in the process of filling up vacancies in the project entitled “Translational Research Program” and other related projects.

Post : Scientist C (Clinical)

At Indegene, we look to change healthcare for the better. Being an Indegene employee is not just doing a job, but it is about real contribution and outcomes. We are a global team of over 1,200 employees across 14 global locations. Our singular focus is to deliver real outcomes that are measurable, impactful, and sustainable. This has made us a recognized global leader and partner to some of the largest and most respected healthcare organizations.

Post : Manager Scientific Writing - Pharmacovigilance

The Government of Haryana has established a Medical College and Hospital with all modern amenities in the heart of Karnal city in the name of Kalpana Chawla, famous astronaut. The Medical College and Hospital is spread over an area of more than 50 acres. With the establishment of this Medical College in Karnal, the hopes and aspirations of the people of the area will be met with the standards of health services going up and students benefiting with the advantage getting better educational avenues in a congenial environment.

Ayushman Bharat - Sarbat Sehat Bima Yojana (AB-SSBY), a flagship state health insurance scheme for the beneficiaires of State of Punjab. AB-SSBY will provide financial protection to 75% population of state of Punjab. It is entitlement based cashless health insurance cover of Rs. 5 Lakh per family per year. Under this scheme, cashless and paperless treatment is available at government and empanelled private hospitals.

About the Mission
The National Biopharma Mission is an Industry-Academia Collaborative Mission of Department of Biotechnology (DBT), Ministry of Science & Technology, Govt. of India for Accelerating Early Development for Biopharmaceuticals; to be implemented by Biotechnology Research Assistance Council (BIRAC)-a Public Sector Undertaking of DBT  Approved by the Government for implementation at a total cost US$ 250 million the Mission is co-funded 50% with World Bank loan assistance.  The Mission Programme is a Pan-India Programme with the main aim of making India a hub for design and development of novel, affordable and effective biopharmaceutical products and solutions. This Program would aid in enhancing India’s innovation research and product development capabilities, especially by focusing on development of vaccines, biologics and medical devices for combating public health concerns. The Program would aid academic researchers (through enhancing their translation capability); empower bio-entrepreneurs and SMEs (by decreased cost and risk during early stages of product development) and the industry (by elevating their innovation quotient). Anticipated long term impact would benefit the Indian population at large benefit due to availability of affordable solutions and products relevant to Indian health needs.